Effects of primary percutaneous coronary intervention on P wave dispersion

Turgay Celik1, Atila Iyisoy, Hurkan Kursaklioglu

  • 1Department of Cardiology, Gulhane Military Medical Academy, Etlik, Ankara, Turkey. benturgay@yahoo.com

Insights

Primary percutaneous coronary intervention (PCI) reduces P wave dispersion (PWD) after acute myocardial infarction. However, prolonged PWD in patients with poor myocardial perfusion after PCI may indicate higher mortality and atrial fibrillation risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Electrophysiology

Background:

  • P wave dispersion (PWD) is elevated following coronary occlusion.
  • The impact of primary percutaneous coronary intervention (PCI) on PWD requires further investigation.

Purpose of the Study:

  • To evaluate the effect of primary PCI on PWD in patients with acute myocardial infarction.
  • To assess the relationship between PWD, myocardial perfusion, and atrial fibrillation (AF) post-PCI.

Main Methods:

  • 125 acute myocardial infarction patients undergoing primary PCI were analyzed.
  • Patients were stratified into three groups based on Thrombolysis In Myocardial Infarction Myocardial Perfusion Grade (TMPG) post-PCI.
  • Electrocardiograms were recorded before and after PCI to measure PWD and Pmax.

Main Results:

  • Primary PCI significantly reduced PWD and Pmax compared to pre-PCI values.
  • Patients with poorer myocardial perfusion (TMPG 0/1 or 2) exhibited higher PWD and Pmax post-PCI.
  • Higher PWD and Pmax were observed in patients who developed atrial fibrillation (AF), with more frequent AF in the poor perfusion group.

Conclusions:

  • Primary PCI effectively decreases PWD and Pmax.
  • Elevated PWD post-PCI, especially in patients with suboptimal myocardial reperfusion, is associated with increased mortality and AF risk.
  • PWD may serve as a predictor of clinical reperfusion and AF following primary PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...